Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Exercise of Options

27 May 2021 07:00

RNS Number : 0098A
Time Finance PLC
27 May 2021
 

27 May 2021

 

 

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Exercise of Employee Options and Director/PDMR Shareholdings

 

Time Finance plc, the AIM listed independent specialist finance provider, announces that as a result of exercises of nil cost share options ("Options") under the Company's Unapproved Share Option Scheme (the "Scheme") on 26 May 2021, the Company has made application for a total of 2,138,500 new ordinary shares in the Company (the "New Ordinary Shares") to be admitted to trading on AIM. The New Ordinary Shares will rank pari-passu with existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 2 June 2021 ("Admission").

 

Of the New Ordinary Shares, an aggregate of 1,236,508 New Ordinary Shares have been sold at a price of 31.65 pence per New Ordinary Shares to meet tax liabilities and national insurance contributions arising from the exercises of Options, with the balance of the New Ordinary Shares being retained by the participants in accordance with the terms of the Scheme.

 

Following admission of the New Ordinary Shares to trading on AIM, the Group's issued ordinary share capital will comprise 92,512,704 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in the Company following admission will be 92,512,704. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Group under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Participant

Position

Options exercised / New Ordinary Shares

New Ordinary

Shares disposed of

James Roberts

CFO

 864,500

525,616

Jennifer Bodey

PDMR

 217,000

121,086

Lorraine Neyland

PDMR

217,000

121,086

Holly Mapstone

PDMR

 168,000

93,744

Alun Winter

PDMR

 168,000

93,744

Phil Chesham

PDMR

 168,000

93,744

Tansy Cunningham

PDMR

 168,000

93,744

David Jones

PDMR

 168,000

93,744

 

As a result of the exercise of Options and taxation related disposal of New Ordinary Shares, James Roberts, the Company's Chief Financial Officer, is now interested in 520,551 ordinary shares, representing 0.5% of the Company's issued ordinary share capital.

 

The notifications below, provided in accordance with the requirements of the UK Market Abuse Regulation, provide further details.

 

For further information, please contact:

Time Finance plc

Ed Rimmer, Interim Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

Cenkos Securities plc (NOMAD)

Max Hartley / Ben Jeynes (Nomad)

Julian Morse (Sales)

0207 397 8900

Walbrook PR

0207 933 8780

Paul Vann / Nicholas Johnson

07768 807631

paul.vann@walbrookpr.com

 

About Time Finance:

Time Finance's strategy is to focus on providing or arranging the finance UK SMEs require to fund their businesses and arranging vehicle and property-backed finance for consumers. The multi-product range for SMEs includes asset, vehicle, loan and invoice finance facilities. The Group operates a "hybrid" lending and broking model enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website www.timefinance.com 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

1. James Roberts

2. Jennifer Bodey

3. Lorraine Neyland

4. Holly Mapstone

5. Alun Winter

6. Phil Chesham

7. Tansy Cunningham

8. David Jones

2

 

Reason for the notification

 

a)

 

Position/status

1. Chief Finance Officer

2. PDMR

3. PDMR

4. PDMR

5. PDMR

6. PDMR

7. PDMR

8. PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

1pm plc

b)

 

LEI

 

213800VG3QJGBP2MKR86

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

 

 

b)

 

Nature of the transaction

 

Exercise of nil cost share options under Unapproved Share Option Scheme

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1. Nil pence

2. Nil pence

3. Nil pence

4. Nil pence

5. Nil pence

6. Nil pence

7. Nil pence

8. Nil pence

 

1. 864,500

2. 217,000

3. 217,000

4. 168,000

5. 168,000

6. 168,000

7. 168,000

8. 168,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a - see table above

e)

 

Date of the transaction

 

26 May 2021

f)

 

Place of the transaction

Outside of a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

1. James Roberts

2. Jennifer Bodey

3. Lorraine Neyland

4. Holly Mapstone

5. Alun Winter

6. Phil Chesham

7. Tansy Cunningham

8. David Jones

2

 

Reason for the notification

 

a)

 

Position/status

1. Chief Finance Officer

2. PDMR

3. PDMR

4. PDMR

5. PDMR

6. PDMR

7. PDMR

8. PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

1pm plc

b)

 

LEI

 

213800VG3QJGBP2MKR86

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

 

 

b)

 

Nature of the transaction

 

Sale of ordinary shares of 10p each pursuant to exercises of nil cost share options under Unapproved Share Option Scheme

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1. 31.65 pence

2. 31.65 pence

3. 31.65 pence

4. 31.65 pence

5. 31.65 pence

6. 31.65 pence

7. 31.65 pence

8. 31.65 pence

 

1. 525,616

2. 121,086

3. 121,086

4. 93,744

5. 93,744

6. 93,744

7. 93,744

8. 93,744

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a - see table above

e)

 

Date of the transaction

 

26 May 2021

f)

 

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEDLBLFELXBBV
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.